NHS to receive £250m for new AI lab

The NHS will receive a £250 million ($303m) investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

UK life sciences partnership to use AI in disease detection

5 December 2018 The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.

Big Pharma

NHS partners with drugmakers to eliminate hep C

3 May 2019 The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England.

Europe

UK Supreme Court shoots down NHS £220m drug patent suit

2 July 2021 The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.

More on this story

Big Pharma

UK life sciences partnership to use AI in disease detection

5 December 2018 The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.

Big Pharma

NHS partners with drugmakers to eliminate hep C

3 May 2019 The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England.

Europe

UK Supreme Court shoots down NHS £220m drug patent suit

More on this story

Big Pharma

UK life sciences partnership to use AI in disease detection

5 December 2018 The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.

Big Pharma

NHS partners with drugmakers to eliminate hep C

3 May 2019 The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England.

Europe

UK Supreme Court shoots down NHS £220m drug patent suit